Literature DB >> 12599261

Characterization of antibody binding to three cancer-related antigens using flow cytometry and cell tracking velocimetry.

E Julia Chosy1, Masayuki Nakamura, Kristie Melnik, Kristin Comella, Larry C Lasky, Maciej Zborowski, Jeffrey J Chalmers.   

Abstract

Proper antibody labeling is a fundamental step in the positive selection/isolation of rare cancer cells using immunomagnetic cell separation technology. Using either a two-step or single-step labeling protocol, we examined a combination of six different antibodies specific for three different antigens (epithelial specific antigen, epithelial membrane antigen, and HER-2/Neu) on two different breast cancer cell lines (HCC1954 and MCF-7). When a two-step labeling protocol was used (i.e., anti-surface marker-fluoroscein-isothiocyanate [FITC] [primary Ab], anti-FITC magnetic colloid [secondary Ab]) saturation of the primary antibody was determined using fluorescence intensity measurements from flow cytometry (FCM). The saturation of the secondary antibody (or saturation of a single-step labeling) was determined using magnetophoretic mobility measurements from cell tracking velocimetry (CTV). When the maximum magnetophoretic mobility was the primary objective, our results demonstrate that the quantities necessary for antibody saturation with respect to fluorescence intensity were generally higher than those recommended by the manufacturer. The results demonstrate that magnetophoretic mobility varies depending on the types of cell lines, primary antibodies, and concentration of secondary magnetic colloid-conjugated antibody. It is concluded that saturation studies are a vital preparatory step in any separation method involving antibody labeling, especially those that require the specificity of rare cell detection. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12599261     DOI: 10.1002/bit.10581

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  6 in total

1.  Magnetic needles and superparamagnetic cells.

Authors:  H C Bryant; D A Sergatskov; Debbie Lovato; Natalie L Adolphi; Richard S Larson; Edward R Flynn
Journal:  Phys Med Biol       Date:  2007-06-08       Impact factor: 3.609

2.  Quantitative characterization of the regulation of iron metabolism in glioblastoma stem-like cells using magnetophoresis.

Authors:  Kyoung-Joo J Park; James Kim; Thomas Testoff; Joseph Adams; Miranda Poklar; Maciej Zborowski; Monica Venere; Jeffrey J Chalmers
Journal:  Biotechnol Bioeng       Date:  2019-04-24       Impact factor: 4.530

3.  Cholesterol loading and ultrastable protein interactions determine the level of tumor marker required for optimal isolation of cancer cells.

Authors:  Jayati Jain; Gianluca Veggiani; Mark Howarth
Journal:  Cancer Res       Date:  2013-02-01       Impact factor: 12.701

4.  Differences in magnetically induced motion of diamagnetic, paramagnetic, and superparamagnetic microparticles detected by cell tracking velocimetry.

Authors:  Xiaoxia Jin; Yang Zhao; Aaron Richardson; Lee Moore; P Stephen Williams; Maciej Zborowski; Jeffrey J Chalmers
Journal:  Analyst       Date:  2008-09-09       Impact factor: 4.616

5.  Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells.

Authors:  Liying Yang; James C Lang; Priya Balasubramanian; Kris R Jatana; David Schuller; Amit Agrawal; Maciej Zborowski; Jeffrey J Chalmers
Journal:  Biotechnol Bioeng       Date:  2009-02-01       Impact factor: 4.530

6.  Intrinsically magnetic susceptibility in human blood and its potential impact on cell separation: Non-classical and intermediate monocytes have the strongest magnetic behavior in fresh human blood.

Authors:  Jenifer Gómez-Pastora; James Kim; Victor Multanen; Mitchell Weigand; Nicole A Walters; Eduardo Reátegui; Andre F Palmer; Mark H Yazer; Maciej Zborowski; Jeffrey J Chalmers
Journal:  Exp Hematol       Date:  2021-05-18       Impact factor: 3.249

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.